Merrimack Pharma (MACK) Rips Higher on Baxter (BAX) Agreement
Tweet Send to a Friend
Merrimack Pharmaceuticals (Nasdaq: MACK) shares are ripping in early trading following news that the company entered an exclusive agreement with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE